HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 64, Number 4, February 22, 2005 Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Udd, B. Articles by Hackman, P. Search for Related Content PubMed Articles by Udd, B. Articles by Hackman, P. Related Collections Muscle disease All Genetics

Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J

From the Neurological Department (Dr. Udd, A. Vihola), Vaasa Central Hospital, Department of Neurology (Dr. Udd), Tampere University Hospital, and Folkhälsan Institute of Genetics and Department of Medical Genetics (Dr. Hackman, A. Vihola and J. Sarparanta), University of Helsinki, Finland; and Généthon-CNRS8115 (Dr. Richard), Evry, France.

Address correspondence and reprint requests to Dr. B. Udd, Department of Neurology, Vaasa Central Hospital, FIN-65130 Vaasa, Finland; e-mail: Bjarne.Udd{at}vshp.fi

Objective: To determine the phenotype variability associated with the specific C-terminal M-line titin mutation known to cause autosomal dominant distal myopathy, tibial muscular dystrophy (TMD; MIM 600334), and limb girdle muscular dystrophy 2J (LGMD2J).

Methods: Three hundred eighty-six individuals were genotyped for the Finnish founder mutation in titin (FINmaj) causing TMD/LGMD2J.

Results: Two hundred seven patients were heterozygous for the mutation. Among these patients, 189 (91%) had a more common phenotype compatible with the classic description of TMD. However, 18 (9%) had unusual phenotypes such as proximal leg or posterior lower leg muscle weakness and atrophy even at onset. Four patients were confirmed homozygotes representing the LGMD2J phenotype. These homozygotes were half of the eight LGMD patients previously described in the original large consanguineous kindred.

Conclusions: Large variability of phenotypic expression caused by just one mutation, the Finnish FINmaj, suggests that no certain phenotype of myopathy/dystrophy can be excluded from being caused by mutated titin. Yet unknown homozygous or compound heterozygous titin mutations without phenotype in the heterozygote carriers may be responsible for undetermined recessive MD and LGMD.

This article has been cited by other articles:

				A. Fukuzawa, S. Lange, M. Holt, A. Vihola, V. Carmignac, A. Ferreiro, B. Udd, and M. Gautel Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band - implications for hereditary myopathies J. Cell Sci., June 1, 2008; 121(11): 1841 - 1851. [Abstract] [Full Text] [PDF]

				W. A. Linke Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction Cardiovasc Res, March 1, 2008; 77(4): 637 - 648. [Abstract] [Full Text] [PDF]

				C. Wallgren-Pettersson, V.-L. Lehtokari, H. Kalimo, A. Paetau, E. Nuutinen, P. Hackman, C. Sewry, K. Pelin, and B. Udd Distal myopathy caused by homozygous missense mutations in the nebulin gene Brain, June 1, 2007; 130(6): 1465 - 1476. [Abstract] [Full Text] [PDF]

				M. C. Olsson, M. Kruger, L.-H. Meyer, L. Ahnlund, L. Gransberg, W. A. Linke, and L. Larsson Fibre type-specific increase in passive muscle tension in spinal cord-injured subjects with spasticity J. Physiol., November 15, 2006; 577(1): 339 - 352. [Abstract] [Full Text] [PDF]

				D. Selcen and K. Bushby Titinopathies: What happens when a big gene mutates in a big family? Neurology, February 22, 2005; 64(4): 596 - 597. [Full Text] [PDF]